http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020536971-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2018-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2020536971-A
titleOfInvention Cyclic dinucleotide as an anticancer drug
abstract The present invention is directed to compounds of the formula. (I) Also defined herein are pharmaceutically acceptable compositions containing any substituents, compounds of the invention and methods using the above compositions in the treatment of various diseases.
priorityDate 2017-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016531842-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017161349-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020511420-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005005450-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020503303-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017027646-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158279529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449080160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467507350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467625408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466076785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468113600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466240470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468113569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467680635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467979581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467044618
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466985665
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468123010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466985663

Total number of triples: 44.